(101 days)
Not Found
No
The document describes a standard PACS system with image processing capabilities and integration with HIS/RIS. There is no mention of AI, ML, or any related technologies in the intended use, device description, or performance studies.
No
This device is a PACS system intended for displaying, processing, and archiving medical images to support diagnosis and treatment planning, not to directly treat a condition.
Yes
The device is intended to assist physicians in diagnosis and treatment planning by displaying, processing, reading, and reporting digital medical images, which are all functions of a diagnostic device.
No
While the device is described as "software only", it also states it can be delivered "preconfigured on hardware" and has "Defined Hardware requirements are to be met." This indicates it is not solely software and relies on specific hardware for its intended function.
Based on the provided text, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. The text describes syngo.plaza as a Picture Archiving and Communication System (PACS) that deals with digital medical images. It processes, displays, stores, and communicates these images.
- The intended use and device description clearly focus on image management and processing for diagnosis and treatment planning based on medical images. There is no mention of analyzing biological samples.
Therefore, syngo.plaza falls under the category of medical imaging software or a PACS, not an IVD.
N/A
Intended Use / Indications for Use
syngo plaza is a Picture Archiving and Communication System (PACS) intended to display, process, read, report, communicate, distribute, store and archive digital medical images.
It supports the physician in diagnosis and treatment planning.
syngo.plaza also supports storage and archiving of DICOM Structured Reports.
In a comprehensive imaging suite syngo.plaza integrates Hospital/Radiology Information Systems (HIS/RIS) to enable customer specific workflows. syngo.plaza optionally uses a variety of advanced postprocessing applications.
Note:
Web-based image distribution is not intended for reporting.
In the U.S.A., syngo.plaza is not intended for the reporting of digital mammography images.
Product codes
LLZ
Device Description
This premarket notification covers Siemens' enhanced PACS system syngo.plaza.
syngo. plaza is a Picture Archiving and Communication System (PACS) intended to display, process, read, report, communicate, distribute, store and archive digital medical images.
It supports the physician in diagnosis and treatment planning.
syngo.plaza also supports storage and archiving of DICOM Structured Reports.
In a comprehensive imaging suite syngo.plaza integrates Hospital/Radiology Information Systems (HIS/RIS) to enable customer specific workflows. syngo. plaza optionally uses a variety of advanced post processing applications.
The three syngo.plaza workplace deployments:
a) syngo.plaza Cluster Client
b) syngo.plaza Web Client
c) syngo.plaza Standalone Workstation
... are medical diagnostic and viewing workstations intended for post processing, reading, reporting, viewing and communicating / distributing of radiological softcopy images and so allow radiologists and radiological technicians to receive and process all data needed.
syngo.plaza is a "software only"-system, which will be delivered on CD-ROM / DVD or also preconfigured on hardware. syngo.plaza will be installed by Siemens service engineers.
Defined Hardware requirements are to be met.
The herewith described syngo.plaza supports DICOM formatted images and objects.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
digital medical images
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
physician, radiologists, radiological technicians
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The software verification and validation (Unit Test Level, Integration Test Level and System Test Level) was performed for all newly developed components and the complete system according the following standards: DICOM Standard [2008], JPEG/JPEG 2000 Standard [1992, 2002], SMPTE Test Pattern [1995], ISO 14971:2007, IEC 60601-1-4 + A1 [1999], IEC 60601-1-6 [2006], HL7 [2006], IEC 62304 [2006].
After completion of the system test and comparison of the test results with the software release acceptance criteria, Siemens is of the opinion, that syngo.plaza is substantially equivalent to and performs as well as the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
510(k) Summary
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
- GENERAL INFORMATION I.
MAR - 4 2010
Establishment:
- Siemens AG. Medical Solutions Address: . Henkestrasse 127 D-91052 Erlangen Germany
- Registration Number: 3002808157 ●
Sabine Schroedel Contact Person: . Regulatory Affairs Manager Telephone: +49 (9131) 84-8285 +49 (9131) 84-2792 Telefax:
Device Name and Classification:
| • Trade Name: | syngo.plaza |
|---|---|
| Classification Name: Picture Archiving and | |
| Communications System | |
| • Classification Panel: | Radiology |
| • CFR Section: | 21 CFR §892.2050 |
| • Device Class: | Class II |
| • Product Code: | LLZ |
Date of Submission:
November 06, 2009
II. SAFETY AND EFFECTIVENESS INFORMATION SUPPORTING THE SUBSTANTIAL EQUIVALENCE DETERMINATION
Device Description and Intended Use: .
This premarket notification covers Siemens' enhanced PACS system syngo.plaza.
syngo. plaza is a Picture Archiving and Communication System (PACS) intended to display, process, read, report, communicate, distribute, store and archive digital medical images.
It supports the physician in diagnosis and treatment planning.
syngo.plaza also supports storage and archiving of DICOM Structured Reports.
1
In a comprehensive imaging suite syngo.plaza integrates Hospital/Radiology Information Systems (HIS/RIS) to enable customer specific workflows. syngo. plaza optionally uses a variety of advanced post processing applications.
Note:
Web-based image distribution is not intended for reporting.
In the U.S.A., syngo.plaza is not intended for the reporting of digital mammography images.
syngo.plaza Workplaces
The three syngo.plaza workplace deployments ...
- a) syngo.plaza Cluster Client
- b) syngo.plaza Web Client
- c) syngo.plaza Standalone Workstation
... are medical diagnostic and viewing workstations intended for post processing, reading, reporting, viewing and communicating / distributing of radiological softcopy images and so allow radiologists and radiological technicians to receive and process all data needed.
By usage of only specific FDA approved monitors validated together with the software, diagnosis on digital mammography images is possible, but it is not supported in the U.S.A. as disclaimed in the Intended Use.
Integration
The integration of syngo.plaza shall be applied at different levels and by using technologies like sharing the same HW/SW platform, using common Siemens Medical components (e.g. OPENLink), offering an open interface for other vendors to connect with other DICOM nodes and especially the DICOM Archive functionality, with other information systems (mainly RIS).
. Technological Characteristics:
syngo.plaza is a "software only"-system, which will be delivered on CD-ROM / DVD or also preconfigured on hardware. syngo.plaza will be installed by Siemens service engineers.
Defined Hardware requirements are to be met.
The herewith described syngo.plaza supports DICOM formatted images and objects.
. Summary of Non-Clinical Testing:
The software verification and validation (Unit Test Level, Integration Test Level and System Test Level) was performed for all newly developed components and the complete system according the following standards: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
-
DICOM Standard [2008]
-
JPEG/JPEG 2000 Standard [1992, 2002]
-
SMPTE Test Pattern [1995]
-
ISO 14971:2007
-
IEC 60601-1-4 + A1 [1999]
-
IEC 60601-1-6 [2006]
2
- HL7 [2006]
- IEC 62304 [2006]
After completion of the system test and comparison of the test results with the software release acceptance criteria, Siemens is of the opinion, that syngo.plaza is substantially equivalent to and performs as well as the predicate device.
General Safety and Effectiveness Concerns: .
The device labelling contains instructions for use and any necessary cautions and warning, to provide for safe and effective use of the device.
Risk management is ensured via a risk analysis, which is used to identify potential hazards. These potential hazards are controlled via software development, verification and validation testing.
Substantial Equivalence: .
The syngo.plaza, addressed in this special premarket notification, is substantially equivalent to the following commercially available device:
| Siemens | VO 1190
maging
SUNOO
| 17000100
| AU024 |
|---|
| --------- |
| . |
| |
The syngo.plaza described in this 510(k) has the same intended use and similar technical characteristics as the device listed above in regard to the specific functionalities. In summary. Siemens is of the opinion that syngo.plaza does not introduce any new potential safety risks and is substantially equivalent to and performs as well as the predicate devices.
3
Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure with three curved lines forming its body and wings. The logo is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" in a circular arrangement.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Siemens AG Medical Solutions . % Mr. Stefan Preiss Responsible Third Party Official TÜV SÜD America 1775 Old Hwy 8 NW, Ste 104 NEW BRIGHTON MN 55112-1891
MAR - 4 2010
Re: K093612
Trade/Device Name: syngo, plaza Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: February 10, 2010
Received: February 16, 2010
Dear Mr. Preiss:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendmouts, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (DMA). You may, therefore, market the device, subject to the general controls provisions of the Act . The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish firther. announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. Your must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
4
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Amlt
Donald J. St.Pierre Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
.
5
INDICATIONS FOR USE
Image /page/5/Picture/19 description: The image shows a simple line drawing of a rectangular shape. The rectangle is slightly tilted, giving it a dynamic appearance. The lines are clean and create a clear outline of the shape, set against a plain white background.
| 510(k) Number (if known): | |
|---|---|
| Device Name: | syngo plaza |
Indications For Use:
syngo plaza is a Picture Archiving and Communication System (PACS) intended to display, process, read, report, communicate, distribute, store and archive digital medical images.
It supports the physician in diagnosis and treatment planning.
syngo.plaza also supports storage and archiving of DICOM Structured Reports.
In a comprehensive imaging suite syngo.plaza integrates Hospital/Radiology Information Systems (HIS/RIS) to enable customer specific workflows. syngo.plaza optionally uses a variety of advanced postprocessing applications.
Note:
Web-based image distribution is not intended for reporting.
In the U.S.A., syngo.plaza is not intended for the reporting of digital mammography images.
X Prescription Use (Part 21 CFR 801 Subpart D)
AND / OR
Over-The-Counter Use (Part 21 CFR 801 Subpart C)
(Please do not write below this line - continue on another page if needed) wawwaawaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
Concurrence of the CDRH, Office of Device-Evaluation (ODE) ODVD
(Division Sign-Off)
Division of Radiological Devices
Office of In Vitro Diagnostic Device Evaluation and Safety